PURL: Antidepressant Tx for anxiety disorders: How long?
- PMID: 31532817
- PMCID: PMC6763214
PURL: Antidepressant Tx for anxiety disorders: How long?
Abstract
This systematic review/meta-analysis provides some long-awaited evidence regarding the length of time to treat to minimize the risk of relapse.
Comment on
-
Risk of relapse after antidepressant discontinuation in anxiety disorders, obsessive-compulsive disorder, and post-traumatic stress disorder: systematic review and meta-analysis of relapse prevention trials.BMJ. 2017 Sep 13;358:j3927. doi: 10.1136/bmj.j3927. BMJ. 2017. PMID: 28903922 Free PMC article.
References
-
- Batelaan NM, Bosman RC, Muntingh A, et al. Risk of relapse after antidepressant discontinuation in anxiety disorders, obsessive-compulsive disorder, and post-traumatic stress disorder: systematic review and meta-analysis of relapse prevention trials. BMJ. 2017;358:j3927. Erratum in: BMJ. 2017;358:j4461. - PMC - PubMed
-
- National Institute of Mental Health. Prevalence of any anxiety disorder among adults. https://www.nimh.nih.gov/health/statistics/any-anxiety-disorder.shtml#pa.... Updated November 2017. Accessed July 11, 2019.
-
- Bandelow B, Sher L, Bunevicius R, et al. Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care. Int J Psychiatry Clin Pract. 2012;16:77–84. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
